Status:
NOT_YET_RECRUITING
Comparison of Wear Between Two Dual-mobility Acetabular Cups in Patients Undergoing Total Hip Arthroplasty
Lead Sponsor:
GCS Ramsay Santé pour l'Enseignement et la Recherche
Conditions:
Hip Arthroplasty Replacement
Eligibility:
All Genders
55-80 years
Phase:
NA
Brief Summary
In 2022, data from the UK's National Joint Registry (NJR) and the American Joint Replacement Registry (AJRR) indicated that Total Hip Replacement (THR) is the most commonly performed orthopaedic joint...
Detailed Description
In 2022, data from the UK's National Joint Registry (NJR) and the American Joint Replacement Registry (AJRR) indicated that total hip arthroplasty or Total Hip Replacement (THR) is the most commonly p...
Eligibility Criteria
Inclusion
- Patient, male or female, aged between 55 and 80.
- Patient with a life expectancy \> 5 years at the time of inclusion.
- Patient scheduled to undergo primary total hip arthroplasty with a dual-mobility cup prosthesis.
- Patient affiliated with or beneficiary of a social security scheme.
- Patient who speaks French and has signed an informed consent form.
Exclusion
- Patients with a contraindication mentioned in the instructions for use of the medical device under investigation
- Patients with an ASA score of 4
- Protected patients: adults under guardianship, curatorship or other legal protection, deprived of their liberty by judicial or administrative decision
- Patients participating in another clinical study whose objectives could interfere with this study
Key Trial Info
Start Date :
November 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2036
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT07207005
Start Date
November 15 2025
End Date
August 31 2036
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Privé Jean Mermoz
Lyon, France, France, 69008